Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;30(4):647-656.
doi: 10.1007/s12282-023-01459-0. Epub 2023 Apr 27.

Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2-N3 status patients: a SEER database analysis

Affiliations

Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2-N3 status patients: a SEER database analysis

Yile Jiao et al. Breast Cancer. 2023 Jul.

Abstract

Objective: We aim to use the SEER database to discuss the effect of various surgical methods of primary foci and other influencing factors on the nonregional lymph node (NRLN) metastasis in invasive ductal carcinoma (IDC) patients.

Methods: Clinical information of IDC patients used in this study was obtained from the SEER database. The statistical analyses used included a multivariate logistic regression model, the chi-squared test, log-rank test and propensity score matching (PSM).

Results: 243,533 patients were included in the analysis. 94.3% of NRLN patients had a high N positivity (N3) but an equal distribution in T status. The proportion of operation type, especially BCM and MRM, differed significantly between the N0-N1 and N2-N3 groups in the NRLN metastasis group and nonmetastasis group. Age > 80 years, positive PR, modified radical mastectomy (MRM)/radical mastectomy (RM) and radiotherapy for primary tumor were shown to be protective factors for NRLN metastasis, and higher N positivity was the most significant risk factors. N2-N3 patients receiving MRM had a lower metastasis to NRLN than those receiving BCM (1.4% vs 3.7%, P < 0.001), while this relevance was not discovered in N0-N1 patients. In N2-N3 patients, a better OS was observed in MRM group than BCM group (P < 0.001).

Conclusion: MRM exerted a protective effect on NRLN metastasis compared to BCM in N2-N3 patients but not N0-N1 patients. This implies the need for more consideration when choosing the operation methods of primary foci in patients with high N positivity.

Keywords: Breast cancer; Lymph nodes; Mastectomy; Neoplasm metastasis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nash AL, Thomas SM, Plichta JK, Fayanju OM, Hwang ES, Greenup RA, et al. Contralateral axillary nodal metastases: stage IV disease or a manifestation of progressive locally advanced breast cancer? Ann Surg Oncol. 2021;28:5544–52. https://doi.org/10.1245/s10434-021-10461-9 . - DOI - PubMed - PMC
    1. Zhang Z, Zhang Y, Sun X. Therapeutic options for contralateral axillary lymph node metastasis in breast cancer. Curr Probl Cancer. 2021;45:100706. https://doi.org/10.1016/j.currproblcancer.2020.100706 . - DOI - PubMed
    1. Magnoni F, Colleoni M, Mattar D, Corso G, Bagnardi V, Frassoni S, et al. Contralateral axillary lymph node metastases from breast carcinoma: is it time to review TNM cancer staging? Ann Surg Oncol. 2020;27:4488–99. https://doi.org/10.1245/s10434-020-08605-4 . - DOI - PubMed
    1. Daskalova I, Popovska S, Betova T, Velkova A, Ivanova N, Baitchev G, et al. Distant metastasis after radical treatment of breast cancer: risk factors and their prognostic relevance in 378 consecutive patients. J Buon. 2009;14:229–33. - PubMed
    1. Lapcik P, Pospisilova A, Janacova L, Grell P, Fabian P, Bouchal P. How different are the molecular mechanisms of nodal and distant metastasis in luminal a breast cancer? Cancers (Basel). 2020. https://doi.org/10.3390/cancers12092638 . - DOI - PubMed - PMC

LinkOut - more resources